(Total Views: 529)
Posted On: 08/28/2018 6:41:39 PM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: jamesfranklin #27076
last I saw: In 2016, Amarantus disposed of its wholly-owned diagnostics subsidiary, namely, Amarantus Diagnostics, Inc., to Avant Diagnostics, Inc. ("Avant"
(OTCQB: AVDX). Avant, in turn, paid an aggregate consideration of 80,000,000 shares of its common stock and a US$50,000 convertible promissory note for the acquisition
![](/m/images/icons/icon_wink.gif)
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)